U.S. Markets closed

BioDelivery Sciences International (BDSI) Gains But Lags Market: What You Should Know

Zacks Equity Research
Dillard's (DDS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BioDelivery Sciences International (BDSI) closed at $5.30 in the latest trading session, marking a +0.57% move from the prior day. The stock lagged the S&P 500's daily gain of 1.09%. At the same time, the Dow added 0.84%, and the tech-heavy Nasdaq gained 1.42%.

Coming into today, shares of the specialty pharmaceutical company had gained 10.71% in the past month. In that same time, the Medical sector gained 1.58%, while the S&P 500 gained 1.18%.

BDSI will be looking to display strength as it nears its next earnings release. The company is expected to report EPS of -$0.08, up 55.56% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $19.74 million, up 74.99% from the year-ago period.

BDSI's full-year Zacks Consensus Estimates are calling for earnings of -$0.20 per share and revenue of $92.58 million. These results would represent year-over-year changes of +72.6% and +66.39%, respectively.

It is also important to note the recent changes to analyst estimates for BDSI. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.

Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 11.36% higher. BDSI is holding a Zacks Rank of #3 (Hold) right now.

The Medical - Biomedical and Genetics industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 90, which puts it in the top 36% of all 250+ industries.

The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

You can find more information on all of these metrics, and much more, on Zacks.com.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
BioDelivery Sciences International, Inc. (BDSI) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.